275 related articles for article (PubMed ID: 20590641)
21. Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate.
Farinato A; Altamura C; Imbrici P; Maggi L; Bernasconi P; Mantegazza R; Pasquali L; Siciliano G; Lo Monaco M; Vial C; Sternberg D; Carratù MR; Conte D; Desaphy JF
Pharmacol Res; 2019 Mar; 141():224-235. PubMed ID: 30611854
[TBL] [Abstract][Full Text] [Related]
22. Charge at the lidocaine binding site residue Phe-1759 affects permeation in human cardiac voltage-gated sodium channels.
McNulty MM; Edgerton GB; Shah RD; Hanck DA; Fozzard HA; Lipkind GM
J Physiol; 2007 Jun; 581(Pt 2):741-55. PubMed ID: 17363383
[TBL] [Abstract][Full Text] [Related]
23. Channel openings are necessary but not sufficient for use-dependent block of cardiac Na(+) channels by flecainide: evidence from the analysis of disease-linked mutations.
Liu H; Tateyama M; Clancy CE; Abriel H; Kass RS
J Gen Physiol; 2002 Jul; 120(1):39-51. PubMed ID: 12084774
[TBL] [Abstract][Full Text] [Related]
24. Mutations in cardiac sodium channels: clinical implications.
Liu H; Clancy C; Cormier J; Kass R
Am J Pharmacogenomics; 2003; 3(3):173-9. PubMed ID: 12814325
[TBL] [Abstract][Full Text] [Related]
25. Two human paramyotonia congenita mutations have opposite effects on lidocaine block of Na+ channels expressed in a mammalian cell line.
Fan Z; George AL; Kyle JW; Makielski JC
J Physiol; 1996 Oct; 496 ( Pt 1)(Pt 1):275-86. PubMed ID: 8910215
[TBL] [Abstract][Full Text] [Related]
26. The TTX metabolite 4,9-anhydro-TTX is a highly specific blocker of the Na(v1.6) voltage-dependent sodium channel.
Rosker C; Lohberger B; Hofer D; Steinecker B; Quasthoff S; Schreibmayer W
Am J Physiol Cell Physiol; 2007 Aug; 293(2):C783-9. PubMed ID: 17522141
[TBL] [Abstract][Full Text] [Related]
27. Differential interaction of R-mexiletine with the local anesthetic receptor site on brain and heart sodium channel alpha-subunits.
Weiser T; Qu Y; Catterall WA; Scheuer T
Mol Pharmacol; 1999 Dec; 56(6):1238-44. PubMed ID: 10570051
[TBL] [Abstract][Full Text] [Related]
28. Use-dependent block by lidocaine but not amitriptyline is more pronounced in tetrodotoxin (TTX)-Resistant Nav1.8 than in TTX-sensitive Na+ channels.
Leffler A; Reiprich A; Mohapatra DP; Nau C
J Pharmacol Exp Ther; 2007 Jan; 320(1):354-64. PubMed ID: 17005919
[TBL] [Abstract][Full Text] [Related]
29. Cu2+ (1,10 phenanthroline)3 is an open-channel blocker of the human skeletal muscle sodium channel.
Popa MO; Lerche H
Br J Pharmacol; 2006 Apr; 147(7):808-14. PubMed ID: 16432503
[TBL] [Abstract][Full Text] [Related]
30. A disubstituted succinamide is a potent sodium channel blocker with efficacy in a rat pain model.
Priest BT; Garcia ML; Middleton RE; Brochu RM; Clark S; Dai G; Dick IE; Felix JP; Liu CJ; Reiseter BS; Schmalhofer WA; Shao PP; Tang YS; Chou MZ; Kohler MG; Smith MM; Warren VA; Williams BS; Cohen CJ; Martin WJ; Meinke PT; Parsons WH; Wafford KA; Kaczorowski GJ
Biochemistry; 2004 Aug; 43(30):9866-76. PubMed ID: 15274641
[TBL] [Abstract][Full Text] [Related]
31. Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity.
De Bellis M; Carbonara R; Roussel J; Farinato A; Massari A; Pierno S; Muraglia M; Corbo F; Franchini C; Carratù MR; De Luca A; Conte Camerino D; Desaphy JF
Neuropharmacology; 2017 Feb; 113(Pt A):206-216. PubMed ID: 27743929
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of lidocaine's action on subtypes of spinal dorsal horn neurons subject to the diverse roles of Na(+) and K(+) channels in action potential generation.
Wolff M; Schnöbel-Ehehalt R; Mühling J; Weigand MA; Olschewski A
Anesth Analg; 2014 Aug; 119(2):463-470. PubMed ID: 24892804
[TBL] [Abstract][Full Text] [Related]
33. Cocaine binds to a common site on open and inactivated human heart (Na(v)1.5) sodium channels.
O'Leary ME; Chahine M
J Physiol; 2002 Jun; 541(Pt 3):701-16. PubMed ID: 12068034
[TBL] [Abstract][Full Text] [Related]
34. Unexpected mexiletine responses of a mutant cardiac Na+ channel implicate the selectivity filter as a structural determinant of antiarrhythmic drug access.
Sasaki K; Makita N; Sunami A; Sakurada H; Shirai N; Yokoi H; Kimura A; Tohse N; Hiraoka M; Kitabatake A
Mol Pharmacol; 2004 Aug; 66(2):330-6. PubMed ID: 15266024
[TBL] [Abstract][Full Text] [Related]
35. K-aggravated myotonia mutations at residue G1306 differentially alter deactivation gating of human skeletal muscle sodium channels.
Groome JR; Fujimoto E; Ruben PC
Cell Mol Neurobiol; 2005 Nov; 25(7):1075-92. PubMed ID: 16392038
[TBL] [Abstract][Full Text] [Related]
36. Stereoselective effects of mexiletine enantiomers on sodium currents and excitability characteristics of adult skeletal muscle fibers.
De Luca A; Natuzzi F; Lentini G; Franchini C; Tortorella V; Conte Camerino D
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):653-61. PubMed ID: 9053738
[TBL] [Abstract][Full Text] [Related]
37. Local anesthetics disrupt energetic coupling between the voltage-sensing segments of a sodium channel.
Muroi Y; Chanda B
J Gen Physiol; 2009 Jan; 133(1):1-15. PubMed ID: 19088384
[TBL] [Abstract][Full Text] [Related]
38. Effects of a new potent analog of tocainide on hNav1.7 sodium channels and in vivo neuropathic pain models.
Ghelardini C; Desaphy JF; Muraglia M; Corbo F; Matucci R; Dipalma A; Bertucci C; Pistolozzi M; Nesi M; Norcini M; Franchini C; Camerino DC
Neuroscience; 2010 Aug; 169(2):863-73. PubMed ID: 20580661
[TBL] [Abstract][Full Text] [Related]
39. Block of Voltage-Gated Sodium Channels by Aripiprazole in a State-Dependent Manner.
Föhr KJ; Rapp M; Fauler M; Zimmer T; Jungwirth B; Messerer DAC
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361681
[TBL] [Abstract][Full Text] [Related]
40. High-affinity blockade of voltage-operated skeletal muscle sodium channels by 2,6-dimethyl-4-chlorophenol.
Haeseler G; Gudehus S; Bufler J; Dengler R; Leuwer M
Eur J Anaesthesiol; 2006 Mar; 23(3):190-6. PubMed ID: 16430789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
